THE PRESENCE OF RANKL-OPG COMPLEX IN HUMAN OSTEOSARCOMA U2OS

REFERENCES

• Suda , T. ; Takahashi , N. ; Udagawa , N. ; Jimi , E. ; Gillespie , M. T. ; Martin , T. J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families . Endocr. Rev. 1999 , 20 ( 3 ), 345 – 357 .
   PubMed Web of Science ®Google Scholar
• Lacey , D. L. ; Timms , E. , Tan , H. L. ; Kelley , M. J. ; Dunstan , C. R. ; Burgess , T. ; Elliott , R. ; Colombero , A. ; Elliott , G. ; Scully , S. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation . Cell 1998 , 93 ( 2 ), 165 – 176 .
   PubMed Web of Science ®Google Scholar
• Wong , B. R. ; Josien , R. ; Lee , S. Y. ; Sauter , B. ; Li , H. L. ; Steinman , R. M. ; Choi , Y. TRANCE (Tumor Necrosis Factor (TNF)-related Activation-induced Cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific Survival Factor . J. Exp. Med. 1997 , 186 , 2075 – 2080 .
   PubMed Web of Science ®Google Scholar
• Kong , Y. Y. ; Feige , U. ; Sarosi , I. ; Bolon , B. ; Tafuri , S. ; Morony , C. ; Capparelli , J. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand . Nature 1999 , 402 , 304 – 309 .
   PubMed Web of Science ®Google Scholar
• Simonet , W. S. ; Lacey , D. L. ; Dunstan , C. R. ; Kelley , M. ; Chang , M. S. ; Lüthy , R. : Nguyen , H. Q. ; Wooden , S. ; Bennett , L. ; Boone , T. ; Shimamoto , G. ; DeRose , M. ; Elliott , R. ; Colombero , A. ; Tan , H. L. ; Trail , G. ; Sullivan , J. ; Davy , E. ; Bucay , N. ; Renshaw-Gegg , L. ; Hughes , T. M. ; Hill , D. ; Pattison , W. ; Campbell , P. ; Sander , S. ; Van , G. ; Tarpley , J. ; Derby , P. ; Lee , R. ; Boyle , W. J. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density . Cell 1997 , 89 ( 2 ), 309 – 319 .
   PubMed Web of Science ®Google Scholar
• Yasuda , H. ; Shima , N. ; Nakagawa , N. ; Yamaguchi , K. ; Kinosaki , M. ; Mochizuki , S. ; Tomoyasu , A. ; Yano , K. ; Goto , M. ; Murakami , A. ; Tsuda , E. ; Morinaga , T. ; Higashio , K. ; Udagawa , N. ; Takahashi , N. ; Suda , T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL . Proc. Natl. Acad. Sci. USA 1998 , 95 , 3597 – 3602 .
   PubMed Web of Science ®Google Scholar
• Hofbauer , L. C. ; Heufelder , A. E. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology . J. Mol. Med. 2001 , 79 ( 5–6 ), 243 – 253 .
   PubMed Web of Science ®Google Scholar
• Teng , Y-T. A. ; Nguyen , H. ; Gao , X. ; Kong , Y-Y. Gorczynski , R. M. ; Singh , B. ; Ellen , R. P. ; Penninger , J. M. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection . J. Clin. Invest. 2000 , 106 , R59 – R67 .
   PubMed Web of Science ®Google Scholar
• Romas , E. ; Gillespie , M. T. ; Martin , T. J. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis . Bone 2002 , 30 ( 2 ), 340 – 346 .
   PubMed Web of Science ®Google Scholar
• Kotake , S. ; Udagawa , N. ; Hakoda , M. ; Mogi , M. ; Yano , K. ; Tsuda , E. ; Takahashi , K. ; Furuya , T. ; Ishiyama , S. ; Kim , K. J. ; Saito , S. ; Nishikawa , T. ; Takahashi , N. ; Togari , A. ; Tomatsu , T. ; Suda , T. ; Kamatani , N. Activated human T cells directly induce osteoclastogenesis from human monocytes: Possible role of T cells in bone destruction in rheumatoid arthritis patients . Arthritis. Rheum. 2001 , 44 ( 5 ), 1003 – 1012 .
   PubMed Web of Science ®Google Scholar
• Mogi , M. ; Otogoto , J. ; Ota , N. ; Togari , A. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis . J. Dent. Res. 2004 , 83 ( 2 ), 166 – 169 .
   PubMed Web of Science ®Google Scholar
• Mogi , M. ; Otogoto , J. Expression of cathepsin-K in gingival crevicular fluid of patients with periodontitis . Archs. Oral Biol. 2007 , 52 , 894 – 898 .
   PubMed Web of Science ®Google Scholar
• Wakita , T. ; Mogi , M. ; Kurita , K. ; Kuzushima , M. ; Togari , A. Increase in RANKL: OPG ratio in synovial of patients with TMJ disorder . J. Dent. Res. 2006 , 85 ( 7 ), 627 – 632 .
   PubMed Web of Science ®Google Scholar
• Mogi , M. ; Harada , M. ; Riederer , P. ; Narabayashi , H. ; Fujita , K. ; Nagatsu , T. Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from Parkinsonian patients. Neurosci. Lett. 1994, 165, 208–210.
   PubMed Web of Science ®Google Scholar
• Mogi , M. ; Kondo , A. Down-regulation of mTOR leads to up-regulation of osteoprotegerin in bone marrow cells . Biochem. Biophys. Res. Commun. 2009 , 384 , 82 – 86 .
   PubMed Web of Science ®Google Scholar
• Burgess , T. L. ; Qian , Y. ; Kaufman , S. ; Ring , B. D. ; Van , G. ; Capparelli , C. ; Kelley , M. ; Hsu , H. ; Boyle , W. J. ; Dunstan , C. R. ; Hu , S. ; Lacey , D. L. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts . J. Cell Biol. 1999 , 145 ( 3 ), 527 – 538 .
   PubMed Web of Science ®Google Scholar
• Fuller , K. ; Wong , B. ; Fox , S. ; Choi , Y. ; Chambers , T. J. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts . J. Exp. Med. 1998 , 188 ( 5 ), 997 – 1001 .
   PubMed Web of Science ®Google Scholar
• Kotake , S. ; Udagawa , N. ; Takahashi , N. ; Matsuzaki , K. ; Itoh , K. ; Ishiyama , S. ; Saito , S. ; Inoue , K. ; Kamatani , N. ; Gillespie , M. T. ; Martin , T. J. ; Suda , T. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis . J. Clin. Invest. 1999 , 103 , 1345 – 1352 .
   PubMed Web of Science ®Google Scholar